Clinical trial
Higher Dose of Alglucosidase Alpha for Pompe Disease: Long-term Follow-up Study
NCT05017402 is registered in ClinicalTrials.gov with Taipei Veterans General Hospital, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Higher Dose of Alglucosidase Alpha for Pompe Disease: Long-term Follow-up Study
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 1, 2021
- Completion date
- December 31, 2026
- Enrollment
- 36 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.